| __timestamp | Eli Lilly and Company | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 14683100000 | 1162636000 |
| Thursday, January 1, 2015 | 14921500000 | 1396725000 |
| Friday, January 1, 2016 | 15567200000 | 1526100000 |
| Sunday, January 1, 2017 | 16801100000 | 1619600000 |
| Monday, January 1, 2018 | 16811600000 | 1429100000 |
| Tuesday, January 1, 2019 | 17598300000 | 1331200000 |
| Wednesday, January 1, 2020 | 19056500000 | 1375200000 |
| Friday, January 1, 2021 | 21005600000 | 1563000000 |
| Saturday, January 1, 2022 | 21911600000 | 1789600000 |
| Sunday, January 1, 2023 | 27041900000 | 2070000000 |
| Monday, January 1, 2024 | 36624400001 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, the financial health of companies is a key indicator of their market position and innovation capabilities. Over the past decade, Eli Lilly and Company has demonstrated a robust growth trajectory, with its gross profit surging by approximately 84% from 2014 to 2023. This growth reflects its strategic investments in research and development, as well as successful product launches.
In contrast, United Therapeutics Corporation, while smaller in scale, has shown a steady increase in gross profit, growing by nearly 78% over the same period. This growth underscores its focus on niche markets and innovative therapies.
The data highlights the competitive landscape of the pharmaceutical sector, where both giants and niche players can thrive through strategic focus and innovation. As we look to the future, these trends suggest continued growth and transformation in the industry.
Eli Lilly and Company vs Novartis AG: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Eli Lilly and Company vs Zoetis Inc.
Eli Lilly and Company and Bristol-Myers Squibb Company: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Eli Lilly and Company and Walgreens Boots Alliance, Inc.
Who Generates Higher Gross Profit? Eli Lilly and Company or Ascendis Pharma A/S
Key Insights on Gross Profit: Eli Lilly and Company vs MorphoSys AG
Gross Profit Comparison: Eli Lilly and Company and Evotec SE Trends
Gross Profit Analysis: Comparing Eli Lilly and Company and MiMedx Group, Inc.
Key Insights on Gross Profit: Vertex Pharmaceuticals Incorporated vs United Therapeutics Corporation
Key Insights on Gross Profit: Teva Pharmaceutical Industries Limited vs United Therapeutics Corporation
Key Insights on Gross Profit: United Therapeutics Corporation vs Catalent, Inc.
Gross Profit Trends Compared: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.